in

Experts Debate Whether IRA Provisions Stifle Pharma Innovation at Senate Hearing

Source link : https://www.newshealth.biz/health-news/experts-debate-whether-ira-provisions-stifle-pharma-innovation-at-senate-hearing/

WASHINGTON — The Inflation Reduction Act (IRA) provisions aimed at lowering prescription drug prices will lead to more pharmaceutical innovation, not less, one witness said at a Senate Finance Committee hearing. “These reforms support innovation in a number of ways — first, by expanding the use of drugs, greater profits in the industry should follow,” […]

Author : News Health

Publish date : 2024-09-18 21:05:22

Copyright for syndicated content belongs to the linked Source.

Amadou Hott Steps Down From African Development Bank As Special Envoy of the President for the Alliance for Green Infrastructure in Africa

Star Raiders defender listed as limited on injury report